Activation of Phase Change Contrast Agents Using Ionizing Radiation

Area of Science:

• Medical Imaging
• Radiation Oncology
• Biophysics

Background:

• Phase change contrast agents (PCCA) are utilized in medical imaging.
• Investigating novel applications for PCCA is crucial for advancing diagnostic and therapeutic techniques.

Purpose of the Study:

• To determine the feasibility of activating Definity-based PCCA using X-ray irradiation.
• To assess the dose-dependent response of PCCA to X-ray exposure.
• To explore the potential of activated PCCA for ultrasound-based radiation dosimetry.

Main Methods:

• Definity PCCA were prepared and injected into gelatin phantoms.
• Phantoms were irradiated with X-rays at doses of 0, 30, 50, and 100 Gy.
• PCCA activation and size distribution were analyzed post-irradiation using microscopy, visual inspection, and ultrasound imaging.

Main Results:

• Definity PCCA demonstrated activation at a threshold dose of 50 Gy.
• Increasing radiation doses beyond 50 Gy resulted in further PCCA activation.
• Changes in PCCA were visually confirmed and observable via ultrasound imaging of phantoms.

Conclusions:

• Definity PCCA can be activated by X-ray irradiation, with a clear dose threshold.
• The observed activation suggests a potential application for PCCA in ultrasound-based radiation dosimetry.
• Further research is warranted to optimize PCCA for radiation dosimetry applications.